CAS 866460-33-5: Setipiprant

Fórmula: C₂₄H₁₉FN₂O₃

InChI: InChI=1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29)

Chave InChI: InChIKey=IHAXLPDVOWLUOS-UHFFFAOYSA-N

SMILES: O=C(O)CN1C=2C=CC(F)=CC2C3=C1CCN(C(=O)C4=CC=CC=5C=CC=CC54)C3

Sinónimos:

• ACT 129968
• 2-(2-(1-Naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid
• Setipiprant
• 8-Fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-5H-pyrido[4,3-b]indole-5-acetic acid
• 5H-Pyrido[4,3-b]indole-5-acetic acid, 8-fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-

2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid

CAS: 866460-33-5

• Fórmula: C₂₄H₁₉FN₂O₃
• Pureza: %
• Cor e Forma: Solid
• Peso molecular: 402.4177

Setipiprant

CAS: 866460-33-5

Setipiprant (ACT-129968) is an oral CRTH2 antagonist for asthma/allergy, targeting PGD2-induced inflammation (IC50: 6.0 nM).

• Fórmula: C₂₄H₁₉FN₂O₃
• Pureza: 99.16%
• Cor e Forma: Solid
• Peso molecular: 402.42

Setipiprant(ACT-129968)

CAS: 866460-33-5

Setipiprant is a CRTH2-selective antagonist, which has been shown to be effective in reducing the …

• Fórmula: C₂₄H₁₉FN₂O₃
• Pureza: Min. 95%
• Peso molecular: 402.42 g/mol